-
The Power of One
A cancer survivor reflects on the stranger who gave him a second chance at life.
by Robert Henslin
-
Yesterday & Today
Who Loves Ya, Baby?Telly Savalas met his match in bladder cancer. Earlier diagnosis and more aggressive treatment might have made a difference.
by Jocelyn Selim
-
Forward Look
Paying a Steep PriceNew laws are pushing health insurers to make oral cancer drugs affordable.
by Betty Russell
-
Forward Look
Fueling the Pediatric Cancer PipelineNew efforts are needed to push the pace of drug development.
by Leah Lawrence
-
Forward Look
When the Cancer Doctor Gets CancerQ & A with breast surgeon Susan Love on her new role: cancer survivor.
by Betty Russell
-
Forward Look
It Takes a VillageImproving pediatric cancer care in developing countries
by Leah Lawrence
-
Survivor Profile
Standing StrongDrawing on strength from her ancestors and lessons from the 1960s, cancer survivor Vernal Branch works to make a difference for the next generation.
by Regina Nuzzo
-
When Less Is More
Studies are finding that aggressive treatment, such as extensive surgery, radiation or chemotherapy, is not always necessary for cancer patients to get good results.
by Alexandra Goho
-
Forward Look
The Proof of the Proton Is in the ResultProton beam radiation therapy is expensive and controversial.
by Stephen Ornes
-
Survivor Profile
Macho ManCarlos De La Cuesta is redefining manhood after prostate cancer.
by Jocelyn Selim
Cancer Talk
Lessons Learned as a Caregiver and Patient
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons